Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Laparoscopic subtotal hysterectomy (LASH) for benign uterine lesion has regained its popularity in the past decade due to its minimal invasiveness that results in less operation time, less blood loss and quicker return to normal activity. The standard surgical procedure in LASH includes separation of adnexa and round ligament from pelvic sidewall or uterus, dissection of the vesico-uterine peritoneum and opening of the paravesical space; followed by amputation of the uterus with energy-producing modalities (such as Harmonic Scalpel, monopolar electrocautery, bipolar electrocautery). Large uteri may result in longer operative time and higher possibility of conversion to laparotomy due to technical difficulty and excessive blood loss. In order to overcome these difficulties, we introduce a modified surgical technique of LASH which incorporated two methods of vessels ligation and laparoscopic in situ morcellation.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| A Modified Technique for Laparoscopic Subtotal Hysterectomy | Procedure | incorporation of two methods of vessels ligation and laparoscopic in situ morcellation |
| Measure | Description | Time Frame |
|---|---|---|
| Operation time | at time of surgery | |
| Intraoperative blood loss | at time of surgery |
| Measure | Description | Time Frame |
|---|---|---|
| Post-operative complications | such as ureteral injury, bowel perforation, conversion to laparotomy, recurrent vaginal bleeding | up to 7 days post operation |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
patients aged 20 years old and above with symtomatic uterine myomas or adenomyosis
Not provided
Not provided
Not provided
Not provided